Company intelligence / Profile preview

Aegis Medical Innovations

Vancouver, British Columbia, Canadaaegis-med.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Aegis Medical Innovations has developed the Sierra Ligation System, a minimally invasive epicardial device designed to close off the left atrial appendage and reduce stroke risk in patients with atrial fibrillation who are not ideal candidates for anticoagulation. The company received FDA Investigational Device Exemption approval to begin a U.S. feasibility trial ("LASSO-AF") assessing safety and procedural success. The technology was developed in partnership with Mayo Clinic and aims to offer a safer alternative to endocardial devices by avoiding implantation inside the heart[5][8][10].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Sierra

Phase 1

Indications: Atrial fibrillation, Stroke prevention, Hypertension

Partnerships

Mayo Clinic[5][8]

Beyond the preview

Go deeper on Aegis Medical Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aegis Medical Innovations.

Explore the full profile